Fat Embolism Syndrome: Evolving Perspectives on Diagnosis and Care.

Fat embolism syndrome (FES) is a rare clinical entity. Fat embolization in patients with trauma and long-bone fractures occurs in a majority of patients, and only a few patients develop the triad of skin petechia, respiratory distress, and neurological disturbances, which are termed FES. The exact incidence is not known, as there are no definitive criteria. All English-language publications about FES were searched and reviewed using Google Scholar, PubMed, various databases, conference proceedings, and abstracts, which were included in this study. FES is particularly underdiagnosed and underreported in body contour plastic surgery patients. The following two main theories of FES pathophysiology are proposed: mechanical and biochemical. There are various risk factors for FES, mainly in young patients and bilateral femoral fractures. The diagnosis of FES was traditionally a diagnosis of exclusion. Recently, the combination of clinical parameters and imaging studies has increased the accuracy of FES diagnosis. Point-of-care ultrasound can show fat particles floating from the inferior vena cava to the right heart. MRI is more specific in diagnosing FES with brain involvement. A high index of suspicion, combined with early imaging studies and the application of clinical criteria, must be used to diagnose FES early and accurately. Pharmacological treatments, ranging from ethanol to aspirin, are used without any definitive recommendations. A recent meta-analysis showed the beneficial effect of steroids for FES. The early surgical intervention with open reduction and internal fixation appears to be a better choice, as conservative management and intramedullary nailing increase the risk of systemic fat embolization. The various types of bone reamers were not preventive of FES. The use of reamer irrigation and aspiration systems was found to decrease systemic fat embolization. With all the recent developments in acute and critical care, namely hydration, ventilation, and other resuscitative measures, the outcomes have improved. Blindness due to ophthalmic fat embolism syndrome is rarely reported. The mortality ranges from 5% to 15% in cases of FES.